PETALING JAYA: Nova MSC Bhd
, via its subsidiary, EyRIS Pte Ltd, has secured a contract worth RM7.13mil from JPMCnova Sdn Bhd for the rollout of the national diabetic retinopathy (DR) screening programme in Brunei.
Nova, a provider of industry-focused application software and services for the healthcare sector, said in a statement that Brunei is one of the earliest countries in the world to strengthen its public health system by integrating a deep learning system into their national DR screening programme.
It said the five-year project is set to commence next month and will use EyRIS’ advanced artificial intelligence platforms across hospitals and healthcare centres in the country.
Brunei is facing a growing diabetic population, currently estimated at 13.3%, which translates to about 40,000 citizens.
